These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19668377)

  • 21. Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes?
    Gillberg L; Jacobsen SC; Ribel-Madsen R; Gjesing AP; Boesgaard TW; Ling C; Pedersen O; Hansen T; Vaag A
    PLoS One; 2013; 8(3):e58384. PubMed ID: 23505498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.
    Hernández-Alvarez MI; Thabit H; Burns N; Shah S; Brema I; Hatunic M; Finucane F; Liesa M; Chiellini C; Naon D; Zorzano A; Nolan JJ
    Diabetes Care; 2010 Mar; 33(3):645-51. PubMed ID: 20032281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients.
    Karlsson HK; Ahlsén M; Zierath JR; Wallberg-Henriksson H; Koistinen HA
    Diabetes; 2006 May; 55(5):1283-8. PubMed ID: 16644684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profile in obesity and type 2 diabetes mellitus.
    Das UN; Rao AA
    Lipids Health Dis; 2007 Dec; 6():35. PubMed ID: 18078524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of impaired adipogenesis in insulin resistance.
    Yang X; Jansson PA; Nagaev I; Jack MM; Carvalho E; Sunnerhagen KS; Cam MC; Cushman SW; Smith U
    Biochem Biophys Res Commun; 2004 May; 317(4):1045-51. PubMed ID: 15094374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.
    Bravard A; Lefai E; Meugnier E; Pesenti S; Disse E; Vouillarmet J; Peretti N; Rabasa-Lhoret R; Laville M; Vidal H; Rieusset J
    Diabetes; 2011 Jan; 60(1):258-68. PubMed ID: 20943749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systems biology approach reveals genome to phenome correlation in type 2 diabetes.
    Jain P; Vig S; Datta M; Jindel D; Mathur AK; Mathur SK; Sharma A
    PLoS One; 2013; 8(1):e53522. PubMed ID: 23308243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of microRNA-15a and microRNA-15b in skeletal muscle from adult offspring of women with diabetes in pregnancy.
    Houshmand-Oeregaard A; Schrölkamp M; Kelstrup L; Hansen NS; Hjort L; Thuesen ACB; Broholm C; Mathiesen ER; Clausen TD; Vaag A; Damm P
    Hum Mol Genet; 2018 May; 27(10):1763-1771. PubMed ID: 29528396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients.
    Brown AE; Palsgaard J; Borup R; Avery P; Gunn DA; De Meyts P; Yeaman SJ; Walker M
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E63-70. PubMed ID: 25370850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of insulin receptor substrates (IRS)-1 and IRS-2 and Src homologous and collagen-like protein Shc gene expression by insulin in skeletal muscle is not associated with insulin resistance or type 2 diabetes.
    Huang X; Vaag A; Hansson M; Groop L
    J Clin Endocrinol Metab; 2002 Jan; 87(1):255-9. PubMed ID: 11788655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of genes involved in fatty acid transport and insulin signaling is altered by physical inactivity and exercise training in human skeletal muscle.
    Lammers G; Poelkens F; van Duijnhoven NT; Pardoel EM; Hoenderop JG; Thijssen DH; Hopman MT
    Am J Physiol Endocrinol Metab; 2012 Nov; 303(10):E1245-51. PubMed ID: 23011062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of novel adiponectin receptor-1 transcripts in skeletal muscle of subjects with normal glucose tolerance and type 2 diabetes.
    Ashwal R; Hemi R; Tirosh A; Gordin R; Yissachar E; Cohen-Dayag A; Rosenberg A; Karasik A; Blüher M; Kanety H
    Diabetes; 2011 Mar; 60(3):936-46. PubMed ID: 21289205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.
    Henriksen JE; Alford F; Handberg A; Vaag A; Ward GM; Kalfas A; Beck-Nielsen H
    J Clin Invest; 1994 Sep; 94(3):1196-204. PubMed ID: 8083360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose tolerance is associated with differential expression of microRNAs in skeletal muscle: results from studies of twins with and without type 2 diabetes.
    Bork-Jensen J; Scheele C; Christophersen DV; Nilsson E; Friedrichsen M; Fernandez-Twinn DS; Grunnet LG; Litman T; Holmstrøm K; Vind B; Højlund K; Beck-Nielsen H; Wojtaszewski J; Ozanne SE; Pedersen BK; Poulsen P; Vaag A
    Diabetologia; 2015 Feb; 58(2):363-73. PubMed ID: 25403480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway.
    Granjon A; Gustin MP; Rieusset J; Lefai E; Meugnier E; Güller I; Cerutti C; Paultre C; Disse E; Rabasa-Lhoret R; Laville M; Vidal H; Rome S
    Diabetes; 2009 Nov; 58(11):2555-64. PubMed ID: 19720801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of early gene response to a mixed meal in skeletal muscle in obesity and type 2 diabetes.
    Makhnovskii PA; Lednev EM; Gavrilova AO; Kurochkina NS; Vepkhvadze TF; Shestakova MV; Popov DV
    Physiol Genomics; 2023 Oct; 55(10):468-477. PubMed ID: 37545425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes.
    Fink LN; Oberbach A; Costford SR; Chan KL; Sams A; Blüher M; Klip A
    Diabetologia; 2013 Jul; 56(7):1623-8. PubMed ID: 23595247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.